Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms oleh Justin Watts, Mark D. Minden, Kimo Bachiashvili, Andrew M. Brunner, Sameem Abedin, Timothy Crossman, Magdalena Zajac, Veronica Moroz, Jacqueline L. Egger, Aarti Tarkar, Brandon E. Kremer, Olena Barbash, Gautam Borthakur